4//SEC Filing
Milligan John C.K. IV 4
Accession 0001387131-19-006246
CIK 0000025743other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 4:56 PM ET
Size
7.4 KB
Accession
0001387131-19-006246
Insider Transaction Report
Form 4
Milligan John C.K. IV
DirectorPresident, Secretary, Director10% Owner
Transactions
- Purchase
Common Stock
2019-08-16$2.93/sh+10,000$29,300→ 3,582,373 total(indirect: See Footnote)
Holdings
- 434,814(indirect: See Footnote)
Common Stock
- 1,472,419
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.87 to $2.99, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in Footnote (1) to this Form 4.
- [F2]Shares are owned by John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended.
- [F3]Shares are owned by the Milligan Irrevocable Nonexempt Trust - 2014. These securities are held in a trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001532230
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 4:56 PM ET
- Size
- 7.4 KB